Plunkett Research Online: NLS Pharmaceutics Ltd

NLS PHARMACEUTICS LTD (NLSP) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agon.....


NLS PHARMACEUTICS LTD

Ticker: NLSP
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 41 416188000
Fax: 41 416188009
Address: Alter Postplatz 2
Stans, Switzerland

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Alexander ZwyerCEO/Director
Elena Thyen-PighinCFO/Other Corporate Officer
See More
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agon.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture